SEARCH

SEARCH BY CITATION

2002 ARHP Merit Award Nominations Due April 5

  1. Top of page
  2. ARHP Annual Scientific Meetings
  3. 2002 ARHP Merit Award Nominations Due April 5
  4. 2002 Call for ARHP Abstracts
  5. Siblings Needed for Ankylosing Spondylitis Study
  6. Scleroderma Registry
  7. Request for Referral of Subjects Who Have Developed Myositis After Immunizations (Vaccinations)

Nominations for the 2002 ARHP Merit Awards are being accepted through April 5, 2002. The Distinguished Scholar Award, the Addie Thomas Service Award, and the Lifetime Achievement Award will be presented at the Annual Scientific Meeting in New Orleans. Applications are available on the website, or by calling 404-633-3777 and asking for the ARHP Membership Department

Distinguished Scholar Award Criteria. ARHP member not on the Executive Committee; Publication of papers in peer-reviewed journals, with preference given to candidates who are first or senior authors; Publication of books; Research activities, including grants received; Publication of book chapters, abstracts, or nonrefereed articles; Professional and scientific presentations based upon the individual's expertise; Grants submitted but not awarded; Editor, or on editorial board of a refereed journal; Development of a creative work or educational program

Addie Thomas Service Award Criteria. ARHP member not on the Executive Committee; Length of service in the field of rheumatology; Quality of supporting documents and information in the application; Volunteer contributions and/or recognition on the local, regional, or national level

Lifetime Achievement Award Criteria. Ten years or more of ARHP (Formerly AHPA) membership, but not currently on the Executive Committee; Evidence that a major portion of the candidate's work has been devoted to arthritis-related issues; Evidence of unique and distinguished contributions to research and/or health care, education and service including but not limited to a program of research that has led to new knowledge or unique insights concerning rheumatic disease, the development of a unique and validated approach to patient care, patient or professional education, or other issue relevant to the ARHP; and distinguished leadership inthe ARHP and related organizations.

2002 Call for ARHP Abstracts

  1. Top of page
  2. ARHP Annual Scientific Meetings
  3. 2002 ARHP Merit Award Nominations Due April 5
  4. 2002 Call for ARHP Abstracts
  5. Siblings Needed for Ankylosing Spondylitis Study
  6. Scleroderma Registry
  7. Request for Referral of Subjects Who Have Developed Myositis After Immunizations (Vaccinations)

The Call for Abstracts for the ARHP Annual Scientific Meeting to be held October 24–29, 2002, in New Orleans, Louisiana, has been mailed to all members. If you are not a member and would like to receive a copy, or if you have any questions, please contact: Happy Tyree, Manager, ARHP Education Department, 1800 Century Place, Suite 250, Atlanta, GA 30345, Phone: 404-633-3777, Fax: 404-633-1870, E-mail: htyree@rheumatology.org

Submission deadline for paper format is May 15, 2002. Deadline for electronic submission is May 22, 2002. Additional information may be obtained from the ARHP Web site www.rheumatology.org/arhp.

Siblings Needed for Ankylosing Spondylitis Study

  1. Top of page
  2. ARHP Annual Scientific Meetings
  3. 2002 ARHP Merit Award Nominations Due April 5
  4. 2002 Call for ARHP Abstracts
  5. Siblings Needed for Ankylosing Spondylitis Study
  6. Scleroderma Registry
  7. Request for Referral of Subjects Who Have Developed Myositis After Immunizations (Vaccinations)

NIAMS has awarded a grant to establish the North American Spondylitis Consortium (NASC) to search for genes that cause ankylosing spondylitis (AS). If you know a patient with AS who has a sibling with AS, please contact the NASC. Enrollment consists of an interview, verification of diagnosis, and a blood sample. AS diagnosis must be confirmed with x-rays of sacroiliac joints. NASC medical centers can offer free x-rays, exams, and the HLA-B27 test to symptomatic family members of a patient with an established diagnosis of AS. Siblings do not need to be near a NASC center to participate. NASC is under the direction of John Reveille, MD, University of Texas, Houston Medical Center, and includes 9 university medical centers and the Spondylitis Association of America. For more information: phone 1-888-777-1594; e-mail info@asresearch.org; Web site www.asresearch.org.

Scleroderma Registry

  1. Top of page
  2. ARHP Annual Scientific Meetings
  3. 2002 ARHP Merit Award Nominations Due April 5
  4. 2002 Call for ARHP Abstracts
  5. Siblings Needed for Ankylosing Spondylitis Study
  6. Scleroderma Registry
  7. Request for Referral of Subjects Who Have Developed Myositis After Immunizations (Vaccinations)

A population-based registry of scleroderma patients in the Detroit metropolitan area has been established at Wayne State University, through funding from NIAMS. The purpose of the Registry is to determine prevalence, incidence, and mortality rates, and to facilitate scleroderma research by physicians and scientists across the US. Contact Swan Atty, MPA, 1-800-736-6864 or 313-966-7777 (fax 313-966-7776), or Maureen D. Mayes, MD, MPH, 313-577-1133.

Request for Referral of Subjects Who Have Developed Myositis After Immunizations (Vaccinations)

  1. Top of page
  2. ARHP Annual Scientific Meetings
  3. 2002 ARHP Merit Award Nominations Due April 5
  4. 2002 Call for ARHP Abstracts
  5. Siblings Needed for Ankylosing Spondylitis Study
  6. Scleroderma Registry
  7. Request for Referral of Subjects Who Have Developed Myositis After Immunizations (Vaccinations)

The Laboratory of Molecular and Developmental Immunology of the Food and Drug Administration invites referral of subjects for a study of the possible relationship between immunizations (vaccinations) and myositis. Subjects will be anyone who received any type of vaccine and then developed any form of myositis, either juvenile or adult (including polymyositis and dermatomyositis), within 6 months, as well as individuals who received the same vaccine and are well. Enrollment consists of completion of a questionnaire and donation of a blood sample through a local physician. For further information, contact: Ejaz Shamim, MD, or Frederick W. Miller, MD, PhD, Laboratory of Molecular and Developmental Immunology, CBER, FDA, Building 29B, Room 2G11, HFM-561, Bethesda, MD 20892; phone 301-827-0459 or 301-827-0659; fax 301-827-0852; e-mail: shamim@cber.fda.gov or miller@cber.fda.gov.